ACTG Publications

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.Simpson, Kit N ; Dietz, Birgitta ; Baran, Robert W ; Garren, Kevin W ; Riddler, Sharon A ; Bhor, Menaka ; Haubrich, Richard H2011Cost Eff Resour Alloc9
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.Hulgan, Todd ; Haubrich, Richard ; Riddler, Sharon A ; Tebas, Pablo ; Ritchie, Marylyn D ; McComsey, Grace A ; Haas, David W ; Canter, Jeffrey A2011 Jan 2AIDS125
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.Tenorio, Allan R ; Jiang, Hongyu ; Zheng, Yu ; Bastow, Barbara ; Kuritzkes, Daniel R ; Bartlett, John A ; Deeks, Steven G ; Landay, Alan L ; Riddler, Sharon A2009 FebAIDS Res Hum Retroviruses225
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.John, Mina ; Heckerman, David ; James, Ian ; Park, Lawrence P ; Carlson, Jonathan M ; Chopra, Abha ; Gaudieri, Silvana ; Nolan, David ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Mallal, Simon2010 Apr 15J Immunol8184
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.Mugavero, Michael J ; May, Margaret ; Ribaudo, Heather J ; Gulick, Roy M ; Riddler, Sharon A ; Haubrich, Richard ; Napravnik, Sonia ; Abgrall, Sophie ; Phillips, Andrew ; Harris, Ross ; Gill, M John ; de Wolf, Frank ; Hogg, Robert ; Günthard, Huldrych F ; Chêne, Geneviève ; D'Arminio Monforte, Antonella ; Guest, Jodie L ; Smith, Colette ; 2011 Nov 1J Acquir Immune Defic Syndr358
Class-sparing regimens for initial treatment of HIV-1 infection.Riddler, Sharon A ; Haubrich, Richard ; DiRienzo, A Gregory ; Peeples, Lynne ; Powderly, William G ; Klingman, Karin L ; Garren, Kevin W ; George, Tania ; Rooney, James F ; Brizz, Barbara ; Lalloo, Umesh G ; Murphy, Robert L ; Swindells, Susan ; Havlir, Diane ; Mellors, John W ; AIDS Clinical Trials Group Study A5142 Team2008 May 15N Engl J Med20358
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.Ribaudo, Heather J ; Smith, Kimberly Y ; Robbins, Gregory K ; Flexner, Charles ; Haubrich, Richard ; Chen, Yun ; Fischl, Margaret A ; Schackman, Bruce R ; Riddler, Sharon A ; Gulick, Roy M2013 DecClin Infect Dis1157
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.Gandhi, Rajesh T ; McMahon, Deborah K ; Bosch, Ronald J ; Lalama, Christina M ; Cyktor, Joshua C ; Macatangay, Bernard J ; Rinaldo, Charles R ; Riddler, Sharon A ; Hogg, Evelyn ; Godfrey, Catherine ; Collier, Ann C ; Eron, Joseph J ; Mellors, John W ; ACTG A5321 Team2017 AprPLoS Pathog413
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.Riddler, Sharon A ; Jiang, Hongyu ; Tenorio, Allan ; Huang, Hairong ; Kuritzkes, Daniel R ; Acosta, Edward P ; Landay, Alan ; Bastow, Barbara ; Haas, David W ; Tashima, Karen T ; Jain, Mamta K ; Deeks, Steven G ; Bartlett, John A2007Antivir Ther412
Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.Zheng, Yu ; Hughes, Michael D ; Lockman, Shahin ; Benson, Constance A ; Hosseinipour, Mina C ; Campbell, Thomas B ; Gulick, Roy M ; Daar, Eric S ; Sax, Paul E ; Riddler, Sharon A ; Haubrich, Richard ; Salata, Robert A ; Currier, Judith S2014 Sep 15Clin Infect Dis659
Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142.Huang, Jeannie S ; Hughes, Michael D ; Riddler, Sharon A ; Haubrich, Richard H ; Aids Clinical Trials Group A5142 Study Team2013 Sep-OctHIV Clin Trials514
Peripheral neuropathy in ART-experienced patients: prevalence and risk factors.Chen, Huichao ; Clifford, David B ; Deng, Lijuan ; Wu, Kunling ; Lee, Anthony J ; Bosch, Ronald J ; Riddler, Sharon A ; Ellis, Ronald J ; Evans, Scott R2013 DecJ Neurovirol619
Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.Riddler, Sharon A ; Aga, Evgenia ; Bosch, Ronald J ; Bastow, Barbara ; Bedison, Margaret ; Vagratian, David ; Vaida, Florin ; Eron, Joseph J ; Gandhi, Rajesh T ; Mellors, John W ; ACTG A5276s Protocol Team2016 Feb 15J Infect Dis4213
HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.Besson, Guillaume J ; Lalama, Christina M ; Bosch, Ronald J ; Gandhi, Rajesh T ; Bedison, Margaret A ; Aga, Evgenia ; Riddler, Sharon A ; McMahon, Deborah K ; Hong, Feiyu ; Mellors, John W2014 Nov 1Clin Infect Dis959
Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionHaubrich, Richard H ; Riddler, Sharon A ; Ribaudo, Heather ; Direnzo, Gregory ; Klingman, Karin L ; Garren, Kevin W ; Butcher, David L ; Rooney, James F ; Havlir, Diane V ; Mellors, John W ; AIDS Clinical Trials Group (ACTG) A5160 and A5142 Study Teams2011 Nov 28AIDS1825
Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.Carlson, Jonathan M ; Brumme, Chanson J ; Martin, Eric ; Listgarten, Jennifer ; Brockman, Mark A ; Le, Anh Q ; Chui, Celia K S ; Cotton, Laura A ; Knapp, David J H F ; Riddler, Sharon A ; Haubrich, Richard ; Nelson, George ; Pfeifer, Nico ; Deziel, Charles E ; Heckerman, David ; Apps, Richard ; Carrington, Mary ; Mallal, Simon ; Harrigan, 2012 DecJ Virol2486
Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase.Brehm, Jessica H ; Lalama, Christina M ; Hughes, Michael D ; Haubrich, Richard ; Riddler, Sharon A ; Sluis-Cremer, Nicolas ; Mellors, John W ; AIDS Clinical Trials Group Study A5142 Protocol Team2011 AprJ Acquir Immune Defic Syndr456
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.Kuritzkes, Daniel R ; Ribaudo, Heather J ; Squires, Kathleen E ; Koletar, Susan L ; Santana, Jorge ; Riddler, Sharon A ; Reichman, Richard ; Shikuma, Cecilia ; Meyer, William A ; Klingman, Karin L ; Gulick, Roy M ; ACTG A5166s Protocol Team2007 Apr 15J Infect Dis8195
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.Almeida, Coral-Ann M ; Bronke, Corine ; Roberts, Steven G ; McKinnon, Elizabeth ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Carlson, Jonathan ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Heckerman, David ; Mallal, Simon ; John, Mina2011 Sep 1J Immunol5187